Medical Defence Union Advises GPs On Pitfalls Of Treating Depression, UK

The Medical Defence Union, the UK's largest medical defence organisation, has revealed it paid out nearly ^Alb3m in compensation on behalf of GP members to settle 30 claims arising from the treatment of patients with depression during a recent ten-year-period.

A Call For Standardized Measurement Of Outcomes In Depression Treatment

Rhode Island Hospital and Brown University researchers are calling on clinicians to adopt a standardized measurement of outcomes when treating depression. The commentary was published in the June edition of Primary Psychiatry.Researchers led by Mark Zimmerman, M.

Astrazeneca Submits Seroquel XR trade; In Europe For The Treatment Of Major Depressive Disorder

AstraZeneca announced that the company has submitted applications in the European Union (EU) for once-daily SEROQUEL XR™ (quetiapine fumarate) Extended-Release Tablets (quetiapine XR), seeking approval for the treatment of major depressive disorder (MDD) including maintenance therapy in adult patients using Mutual Recognition Procedure (MRP).

Study Reveals Rural, Unmarried Women At Higher Risk For Depression

Mayo Clinic research suggests unmarried women living in rural areas have lower self-rated health status than their married counterparts. This lower health status often includes greater instances of self-assessed feelings of depression. The results of the study were recently published in the Journal of Evaluation in Clinical Practice.

Poor Sleep Quality And Insomnia Associated With Suicidal Symptoms Among College Students

Poor sleep quality and insomnia are significantly associated with suicidal symptoms among college undergraduates, according to a research abstract presented on Monday at SLEEP 2008, the 22nd Annual Meeting of the Associated Professional Sleep Societies (APSS).

Ambien CR R zolpidem Tartrate Extended-release CIV Tablets Improved Insomnia And Daily Functioning In Patients With Depressive Disorder

Sanofi-aventis announced results from a new study that showed Ambien CR(R) (zolpidem tartrate extended-release) CIV tablets 12.5 mg provided significant improvement in sleep onset, sleep maintenance and total sleep time over 8 weeks in patients with co-morbid insomnia and major depressive disorder (MDD) who were administered a Selective Serotonin Reuptake Inhibitor (SSRI) for depression.

Suicide Rate In Japan Still Climbing Despite Government Measures

New figures released by the Japanese authorities this week show that the country's suicide rate is still climbing despite government efforts to dramatically reduce the figure by 2016, and the fastest rise appears to be among elderly Japanese, a growing sector of the population that is also experiencing rising poverty.

Scientists Launch Major Study Into Depression

Depression will affect up to 25% of the population at some point in their lives. It also has been shown to have a strong genetic component. For example, if one of your close family members has depression, your chance of also being a sufferer is three to four times the general population risk.

Use Of Antidepressants Reduced By Higher Co-Payments

As they struggle to contain skyrocketing medication costs, health plans across the U.S. have responded by implementing multi-tiered formularies requiring higher copayments for 'non-preferred' medications.

Clarifying The Link Between Diabetes And Depression

A new study in JAMA finds that people who aretreated for type 2 diabetes have higher incidence rates of elevateddepressive symptoms. In the same article, researchers report a modestassociation between the risk of diabetes and persons with depression.